NBIS vs TMO: Which Is the Better Buy?
Side-by-side comparison of Nebius Group N.V. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Nebius Group N.V. · Technology
$217.99
+45.0% upside to fair value
Med Conviction
Grade B
VS
Thermo Fisher Scientific Inc. · Healthcare
$658.32
+31.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
NBIS has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NBIS |
TMO |
| Current Price |
$217.99 |
$658.32 |
| Fair Value Estimate |
$316.09 |
$863.34 |
| Upside to Fair Value |
+45.0%
|
+31.1%
|
| Market Cap |
$52.3B |
$244.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
56.8x
|
25.9x
|
| Price / Sales |
38.6x
|
5.3x
|
| Price / FCF |
—
|
33.4x
|
| Revenue Growth YoY |
+454.0%
|
+10.5%
|
| Gross Margin |
58.6%
|
40.4%
|
| Operating Margin |
-49.3%
|
17.7%
|
| Return on Equity |
0.9%
|
13.4%
|
| Dividend Yield |
0% |
0.28% |
| FCF Yield |
—
|
3.0%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Nebius Group N.V. is an Amsterdam-based AI infrastructure company, formerly Yandex N.V., that builds end-to-end GPU cloud clusters, cloud platforms and developer tools for demanding AI workloads, alongside Toloka AI data solutions, TripleTen education and Avride autonomous driving. The business is growing explosively, with revenue up 454.0% year over year in the most recent quarter, and it has de…
Thermo Fisher Scientific is a global life-sciences and laboratory-services platform spanning Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, with recognized brands including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon, and PPD, serving pharmaceutical, biotech, clinical, academic, and governme…
Accumulation Zones
| Metric |
NBIS |
TMO |
| Zone Low |
$237.07 |
$647.50 |
| Zone High |
$268.68 |
$733.84 |
| In Buy Zone? |
Yes
|
Yes
|